CN100540027C - The Chinese medicine preparation of treatment tachycardia and complication thereof - Google Patents
The Chinese medicine preparation of treatment tachycardia and complication thereof Download PDFInfo
- Publication number
- CN100540027C CN100540027C CNB2006100431489A CN200610043148A CN100540027C CN 100540027 C CN100540027 C CN 100540027C CN B2006100431489 A CNB2006100431489 A CN B2006100431489A CN 200610043148 A CN200610043148 A CN 200610043148A CN 100540027 C CN100540027 C CN 100540027C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- tachycardia
- complication
- tranquilizing
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine preparation of treatment tachycardia and complication thereof belongs to pharmaceutical product.It is to make with Herba Sedi Aizoon 6000-13000 part, Caulis Polygoni Multiflori fine powder 200-400 part, Medulla Junci 100-300 part.The present invention is a monarch drug with Herba Sedi Aizoon heart tonifying and tranquilizing, promoting blood circulation and hemostasis, blood-activating analgetic, the compatibility Caulis Polygoni Multiflori, to strengthen the monarch drug heart tonifying and tranquilizing, again can the wind-damp dispelling the meridian dredging, the lampwick guiding action, inducing diuresis to remove edema, three medicines to be reaching heart tonifying and tranquilizing, promoting blood circulation and hemostasis, the effect of blood-activating analgetic for over 100 years more than a hundred years, Deng family uses the clinical use of we to cardiopalmus, nervous, insomnia, uncomfortable in chest, chest pain, effective percentage is more than 92%, and the transference cure person is more than 68%.
Description
Technical field
The invention belongs to the pharmaceutical product technical field, particularly is the Chinese medicine preparation of feedstock production with Chinese herbal medicine.
Background technology
In the middle of various types of patients with arrhythmia, it is about 5 ‰ that tachycardia accounts for crowd's sickness rate, all very healthy when the patient does not fall ill more than 90%; its morbidity suddenly; heart beating increases suddenly, reaches 160～220/ fens sometimes, even 300 times/minute; the sustainable several seconds of tachycardia; several minutes, a few hours, even a few days; can be through Drug therapy or natural remission; during morbidity, often follow nervous; uncomfortable in chest; discomforts such as giddy particularly merge as coronary heart disease; rheumatic heart disease; severe patient such as congenital heart disease; can cause heart failure; angina pectoris; myocardial infarction etc.; wherein malignant arrhythmia is relevant with sudden death, and when tachycardia was just sent out, attack times was few; but with advancing age; increasing the weight of day by day of heart burden, outbreak can be more and more frequent, and the persistent period is also long more; the physiology output function of heart is poor more; finally make patient's forfeiture orthobiosis and ability to work in various degree, reduce quality of life, even threat to life; therefore, tachycardia has become one of illness of serious harm health.
At present, tachycardia is divided into supraventricular paroxysmal tachycardia and ventricular paroxysmal tachycardia, general tachycardia refers to ventricular paroxysmal tachycardia, ventricular tachycardia choice drug treatment is as many caines, amiodarone, Proca, because of amide, aprindine, norpace (disopyramide) and rhythm of the heart equality.These medicines not only side effect are bigger, and recurrence easily.
Summary of the invention
The object of the invention provides a kind of Chinese medicine preparation for the treatment of tachycardia and complication thereof, to overcome the defective of existing medicine.
Specifically, the Chinese medicine preparation HUOXUEDAN of treatment tachycardia and complication thereof, it is to make with Herba Sedi Aizoon 6000-13000 part, Caulis Polygoni Multiflori fine powder 200-400 part, Medulla Junci 100-300 part.
The preferential prescription of recommending is: 10000 parts of Herba Sedi Aizoons, 300 parts of Caulis Polygoni Multiflori fine powders, Medulla Junci are made for 200 parts.
Adding starch 100-400 part and magnesium stearate are made tablet in right amount in above-mentioned prescription.
The present invention prepares according to following steps:
Find a view a day Radix Notoginseng, Medulla Junci add water for the first time and extracted 120 minutes for 8 times; Adding for the second time water extracted 60 minutes for 6 times, merge extractive liquid, filters, and filtrate is concentrated into 1: 10 (1 milliliter: 10 gram medical herbs), adding equivalent 95% ethanol stirs, left standstill 12-24 hour, and filtered, get supernatant and reclaim ethanol, be concentrated into the 1000-11000 milliliter, get the Caulis Polygoni Multiflori powder, magnesium stearate is an amount of, adds above-mentioned concentrated solution mixed pelletization tabletting, 3000 of total amounts.Every heavy 0.3 gram (every contains former medicine 10 grams)
The present invention is a monarch drug with Herba Sedi Aizoon heart tonifying and tranquilizing, promoting blood circulation and hemostasis, blood-activating analgetic, the compatibility Caulis Polygoni Multiflori, to strengthen the monarch drug heart tonifying and tranquilizing, again can the wind-damp dispelling the meridian dredging, the lampwick guiding action, inducing diuresis to remove edema, three medicines to be reaching heart tonifying and tranquilizing, promoting blood circulation and hemostasis, the effect of blood-activating analgetic for over 100 years more than a hundred years, Deng family uses the clinical use of we to cardiopalmus, nervous, insomnia, uncomfortable in chest, chest pain, effective percentage is more than 92%, and the transference cure person is more than 68%.
The specific embodiment
Prescription of the present invention is: Herba Sedi Aizoon 10000 grams, Caulis Polygoni Multiflori fine powder 300 grams, Medulla Junci 200 grams, starch 300 restrain, magnesium stearate is an amount of.
Preparation technology:
Find a view a day Radix Notoginseng, Medulla Junci add water for the first time and extracted 120 minutes for 8 times; Adding for the second time water extracted 60 minutes for 6 times, merge extractive liquid, filters, and filtrate is concentrated into 1: 10 (1 milliliter: 10 gram medical herbs), adding equivalent 95% ethanol stirs, left standstill 12-24 hour, and filtered, get supernatant and reclaim ethanol, be concentrated into the 1000-11000 milliliter, get the Caulis Polygoni Multiflori powder, magnesium stearate is an amount of, adds above-mentioned concentrated solution mixed pelletization tabletting, 3000 of total amounts.Every heavy 0.3 gram (every contains former medicine 10 grams)
Dosage form: tablet
Function cures mainly: heart tonifying and tranquilizing, promoting blood circulation and hemostasis, blood-activating analgetic; Tachycardia, cardiopalmus, nervous, insomnia, chest pain, uncomfortable in chest.
Usage and dosage: oral 33 times/day
Clinical effectiveness is summed up
1 data and method
1.1 in physical data patient's 80 examples, male 49 examples, women 31 examples, 36～58 years old age.Wherein 16 examples are first outbreak, and all the other all have 3～10 years tachycardia speed histories of attack.All patients all do not have the organic heart disease medical history.
1.2 clinical symptoms and diagnosis
Paroxysmal tachycardia is diagnosed according to different classes of.
(1), paroxysmal auricular tachycardia: 1. continue heartbeat quick and regular more than 3 times, its P waveform attitude is unusual, 2. P-R interval＞0.12s; 3. QRS wave group form is identical with hole.4. the AR per minute is 160-220 time.5. the P ripple is overlapped in the T ripple of last heartbeat and is difficult to recognize sometimes.Can be with one or second degree A-V block.
(2), paroxysmal junctional area tachycardia: 1. continuous atrioventricular junction premature beat more than 3 times or 3 times, frequency per minute 160-250 time, rhythm and pace of moving things rule.2. P` ripple and QRS wave group form have the feature of aforementioned atrioventricular junction place premature beat, the P` ripple can be before the QRS wave group, in or after, be antidromicity.Can be with forward direction or retrograde conduction block in various degree, simultaneously or all atrioventricular dissociation can not occur simultaneously.
(3), paroxysmal ventricular tachycardia: 1. continuous ventricular premature contraction fast more than 3 times, QRS wave group deformity, time 〉=0.12 second, frequency rule or slightly irregular.2. hole P ripple and QRS are irrelevant, are atrioventricular dissociation, and the P wave frequency is slower, are embedded in the QRS wave group so be difficult for finding.3. see ventricular capture and ventricular fusion beat sometimes.The QRS wave group form of ventricular capture is near normal, and idol has the retrograde conduction in room, 1: 1 Room, the P` ripple is arranged behind the QRS wave group, and have V-A block in various degree concurrently.
All patients all show as burst cardiopalmus, breathe hard, outbreak is to the shortest person 10min of the time of examining, elder 50h, dizziness, weak appears in the duration of seizure elder, but has heart failure and shock occurs.The person of examining is capable immediately, and ECG checks, shows that all the rhythm of the heart is definitely regular, 160～180 times/min of heart rate, and the QRS wave group time limit is normal, meets tachycardic diagnosis.
1.3 Therapeutic Method is made a definite diagnosis the oral HUOXUEDAN in back, according to each 3,3 times/day dosage is taken.
2 results
2.1 therapeutic outcome
31 examples are carved to change after taking medicine 15 days and are sinus rhythm again among the patient, change multiple after 32 examples were taken medicine 20 days, and it is longer that total effective rate reaches 90%, 7 routine invalid patient's duration of seizure, and giving quiet notes propafenone 70mg at last changes multiple.
At period in a medicine, do not see that the patient has untoward reaction.
Claims (3)
1, a kind of Chinese medicine preparation for the treatment of tachycardia and complication thereof is characterized in that being made by following raw material of Chinese medicine medicine: Herba Sedi Aizoon 6000-13000 part, Caulis Polygoni Multiflori fine powder 200-400 part, Medulla Junci 100-300 part.
2, the Chinese medicine preparation of treatment tachycardia according to claim 1 and complication thereof is characterized in that being made by following raw material of Chinese medicine medicine: 10000 parts of Herba Sedi Aizoons, 300 parts of Caulis Polygoni Multiflori fine powders, 200 parts of Medulla Juncies.
3, the Chinese medicine preparation of treatment tachycardia according to claim 1 and 2 and complication thereof is characterized in that adding starch 100-400 part and magnesium stearate and makes tablet in right amount.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100431489A CN100540027C (en) | 2006-07-01 | 2006-07-01 | The Chinese medicine preparation of treatment tachycardia and complication thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100431489A CN100540027C (en) | 2006-07-01 | 2006-07-01 | The Chinese medicine preparation of treatment tachycardia and complication thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1899460A CN1899460A (en) | 2007-01-24 |
| CN100540027C true CN100540027C (en) | 2009-09-16 |
Family
ID=37655571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100431489A Expired - Fee Related CN100540027C (en) | 2006-07-01 | 2006-07-01 | The Chinese medicine preparation of treatment tachycardia and complication thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100540027C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843644B (en) * | 2009-10-16 | 2011-06-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating tachycardia |
-
2006
- 2006-07-01 CN CNB2006100431489A patent/CN100540027C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1899460A (en) | 2007-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN100540027C (en) | The Chinese medicine preparation of treatment tachycardia and complication thereof | |
| CN101698050B (en) | Application of traditional Chinese medicine composite in preparing medicine treating paroxysmal atrial fibrillation | |
| CN101637556B (en) | Pharmaceutical composition for treating heart disease and preparation method thereof | |
| CN101721638B (en) | Oral liquor for treating coronary heart disease | |
| CN101342208B (en) | Chinese medicinal composition for treating coronary disease, stenocardia, arrhythmia and preparation method thereof | |
| CN1733242A (en) | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same | |
| CN105213519A (en) | A kind of medicine and preparation method thereof for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny | |
| CN100493527C (en) | Chinese medicine for treating cardiovascular disease and method for preparing same | |
| CN103800723B (en) | One is used for the treatment of ARR Chinese medicine composition and preparation method thereof | |
| CN102293891A (en) | Chinese medicine for treating cardiovascular disease and preparation method thereof | |
| CN111388623B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| Al Harbi et al. | A case of granisetron associated intraoperative cardiac arrest | |
| CN107456481A (en) | A kind of Chinese medicine composition for treating coronary disease and angina pectoris and preparation method thereof | |
| Tandowsky | Prophylactic use of lanatoside C in auricular paroxysmal arrhythmias | |
| CN101647875B (en) | Plant extract for treating bradycardia | |
| CN103566304B (en) | A kind of preparation method for the treatment of the pharmaceutical composition of cardiopalmus | |
| CN106177331A (en) | A kind of Chinese medicine treating hypertension | |
| CN106390025A (en) | Drug for treating coronary heart disease | |
| CN102258523A (en) | Compound preparation for treating hypertension and its preparation method | |
| CN104524313A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome | |
| CN103656501B (en) | The medicine pill for the treatment of spontaneous angina pectoris | |
| CN101461875B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN102327574A (en) | Compound preparation for treating coronary heart disease and preparation method thereof | |
| CN102784201B (en) | A kind of caking for the treatment of is without the pasty medicament of head dummy summer boil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090916 Termination date: 20100701 |